Oversight Project files lawsuit demanding release of Obama-era study examining long-term effects of puberty blockers on transgender children and teens.

Colby is well ahead of the curve for a seventh-round pick, and he's just one of several unheralded rookies contributing for ...

The USC Trojans remain at the top of the 2026 recruiting rankings after the latest update, holding firm with 32 commitments ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of best affordable biotech stocks to invest in now. Regeneron ...

Researchers have identified a molecular biomarker in triple negative breast cancer tumours which could inform when beta blockers can play a role in 'switching off' tumour progression.

Presentation to CDC committee seeks "real classification system to identify and help patients who suffer from an attempt to ...

Beta-blockers, long considered a standard treatment after heart attacks, may not benefit most patients and could increase ...

A new study says a common drug prescribed after a heart attack does not benefit the vast majority of people who take it.

Heart disease has been the leading cause of death in the U.S. for 100 years, according to the American Heart Association’s 2024 Heart Disease and Stroke Statistics report. For decades, beta-blockers ...

AS ERICA FISHER’S nuptials approach, she’s trying to decide: Should she take a beta blocker before she walks down the aisle? Everyone seems to be talking about the drugs, she says—from her favorite ...

Beta-blockers, the gold standard drug treatment for heart attacks, is ineffective for many and may increase the risk of death ...

Two new studies point in opposite directions. A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide ...